Managing symptoms and exacerbations in pediatric asthma

Pediatric Pulmonology

Volumn 24, Issue SUPPL. 15, 1997, Pages 46-50

  Verberne, Anja A P H ^a  

^a Ignatius Hospital   (Netherlands)

Author keywords

Exercise induced asthma; Inhaled corticosteroids; Long acting 2 agonists; Nocturnal asthma; Pediatric asthma; Symptoms and exacerbations

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FORMOTEROL; SALMETEROL; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ASTHMA; CONFERENCE PAPER; DOSE RESPONSE; DRUG MIXTURE; EXERCISE INDUCED ASTHMA; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LIFESTYLE; LONG TERM CARE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; SLEEP DISORDER; ADOLESCENT; CHILD; CLASSIFICATION; DRUG ADMINISTRATION; DRUG COMBINATION; INFANT; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; ASTHMA, EXERCISE-INDUCED; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; INFANT; PRACTICE GUIDELINES;

EID: 0030875377     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199709)15+<46::AID-PPUL10>3.0.CO;2-1     Document Type: Conference Paper

References (22)

1. Bousquet J, Chanez P, Lacoste JY, Barneon G, Chavanian N, Enander I. Eosinophilic inflammation in asthma. N Engl J Med. 1990; 323:1033-1039.
2. Robinson DS, Bentley AM, Hartnell A, Kay AB, Durham SR. Activated memory T-helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and responsiveness. Thorax. 1993; 48:26-32.
3. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis. 1990; 142:863-871.
4. Sont JK, Van Krieken HJM, Evertse CE, Hooijer R, Willems LNA, Sterk PJ. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax. 1996; 51:496-502.
5. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol zinafoate. Arch Dis Child. 1992; 67:1014-1017.
6. Verberne AAPH, Frost C, Roorda RJ, Van der Laag H, Kerrebijn KF, and the Dutch Paediatric Asthma Study Group. One year treatment with salmeterol compared to beclomethasone in children with asthma. Am J Respir Crit Care Med. 1997 (in press).
7. Verberne AAPH, Frost C, Bogaard JM, Kerrebijn KF. Addition of salmeterol versus doubling the dose of an inhaled corticosteroid in children with asthma. Am J Respir Crit Care Med. 1997 (in press).
8. Woodhead M, ed. Guidelines on the management of asthma. Thorax. 1993;48:S1-S24.
9. International Consensus Report on Diagnosis and Treatment of Asthma. National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda. Eur Respir J. 1992; 5:601-641.
10. Warner JO. Asthma: a follow-up statement from an international paediatric asthma consensus group. Arch Dis Child. 1992; 67: 240-248.
11. Anderson S, Seale JP, Ferris L, Scheffel R, Lindsay DA. An evaluation of pharmacotherapy for exercise induced asthma. J Allergy Clin Immunol. 1979; 64:612-624.
12. Boner AL, Spezia E, Piovesan P, Chiocca E, Maiocchi G. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med. 1994; 149:935-939.
13. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990; 142:832-836.
14. Haahtela T, Jarvenin M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, et al. Comparison of a β2 agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991; 325:388-392.
15. Kerstjens HA, Brand PL, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ, Bleecker EJ, Dekhuijzen PN, de-Jong PM, Mengelers HJ, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med. 1992; 327:1413-1419.
16. Van Essen-Zandvliet EEM, Hughes MD, Waalkens HJ, Duiverman EJ, Kerrebijn KF. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide). Can it be achieved? Eur Respir J. 1994; 7:63-68.
17. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijarvi A, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994; 331:700-705.
18. Juniper EF, Kilne PA, Vanzieleghem MA, Hargreave FE. Reduction of budesonide after a year of increased use: a randomised controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol. 1991; 87:483-489.
19. Waalkens HJ, van-Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, Kerrebijn KF. Cessation of long term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis. 1993; 148:1252-1257.
20. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet. 1994; 344:219-224.
21. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. 1996; 153: 1481-1488.
22. Price JF, Weller PH. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Respir Med. 1995; 89:363-368.